US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
FACT II Acquisition Corporation (FACTU) 銘柄情報

FACT II Acquisition Corporation (FACTU)

10.99

0.00

(0.00%)

終了 6月7日 5:00AM

0.00

0.00

(0.00%)

取引時間後: 5:00AM

FACT II Acquisition Corporation (FACTU) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

10.99

( - )

買値

8.14

売値

21.79

出来高

-

0.00 日の範囲 0.00

10.25 52 週間の範囲 12.01

前日終値

10.99

始値

-

時刻

最終取引時間

平均取引量 (3 か月)

160

財務取引量

-

VWAP

-

Precision Aerospace & Defense Group Announces Letter of Intent with Leader in Communications, Security and Surveillance Integration Solutions

Proposed Strategic Acquisition Represents a Major Industry Expansion as Company Advances Toward Public Listing Overland Park, KS, June 05, 2026...

Precision Aerospace & Defense Group, Inc. and FACT II Acquisition Corp. File Amended Registration Statement on Form S-4 in Connection with Proposed Business Combination

Overland Park, KS and New York, NY, May 19, 2026 (GLOBE NEWSWIRE) -- Precision Aerospace & Defense Group, Inc. (“PAD”), a high-growth...

Precision Aerospace & Defense Group, Inc. to Combine with FACT II Acquisition Corp. to Become Publicly Listed Company

Highlights Precision Aerospace & Defense Group, Inc. (“PAD”) to merge with FACT II Acquisition Corp. (NASDAQ: FACT) (“FACT”), creating a...

Form 8-K - Current report

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	10.99	10.99	10.99	1	10.99	CS
4	0	0	10.99	11.12	10.99	0	10.99	CS
12	0.28	2.61437908497	10.71	12.01	10.67	160	10.83167509	CS
26	0	0	10.99	12.01	10.51	483	10.73033914	CS
52	0.44	4.17061611374	10.55	12.01	10.25	1076	10.48197135	CS
156	1.02	10.2306920762	9.97	12.01	9.935	17540	9.97926053	CS
260	1.02	10.2306920762	9.97	12.01	9.935	17540	9.97926053	CS

FACTU - Frequently Asked Questions (FAQ)

What is the current FACT II Acquisition Corporation share price?

The current share price of FACT II Acquisition Corporation is US$ 10.99

What is the 1 year trading range for FACT II Acquisition Corporation share price?

FACT II Acquisition Corporation has traded in the range of US$ 10.25 to US$ 12.01 during the past year

jour_trader

jour_trader 3分前

1.5-2B, but I would expect it to grow over time as well. Perhaps grows into $2.5B? No idea, but pricing pressures will be unlike anything we have seen before.

meixatech

meixatech 5分前

Folks,
IMO it is apparent to me that a major physiological benefit of some ampakines is the potential synergistic effect of combining with other bioactive molecules. Question posed to Google AI:

Would the molecules of the Neuroscience Research Group, Danube Neuroscience Resear

GoonOfWallSt

GoonOfWallSt 6分前

It's oddly quiet from the pumpsh!ts squad side. Did they all take a vacation for the whole month of June to celebrate their pride?

chemist72

chemist72 6分前

For some reason (which I don't understand), the Copilot links give different responses each time I click on them.
THEREFORE, PLEASE TAKE THESE RESULTS WITH CAUTION!! lol

janetcanada

janetcanada 7分前

🙌*** VSMT....& Positive Resumé From "Analyst Stock Titan"....
***https://www.stocktitan.net › news

☯️***From Barchart.....
***https://www.barchart.com/stocks/quotes/VMST/overview

chemist72

chemist72 12分前

Revised Copilot answer. LOL
https://www.bing.com/search?q=What+kind+of+growth+rate+is+required+to+go+from+%245M+in+revenues+to+%241B+in+revenues+over+3+years%2C+5+years+and+10+years%3F&form=ANNTH1&refig=6a25673c262b486cbd9f21ba447dd311&pc=EDGEDSE&adppc=EDGEBRV

M1Maggot

M1Maggot 12分前

I don't really care if they announce that they are selling the dirt on the property for topsoil but these clowns better come out with something that generates income or this stock will hit new lows and SOON !!!!!

jour_trader

jour_trader 13分前

Love seeing the movement on the Oxy patent dispute. We’ll still be held up by FDA even if case is dismissed.

upper11

upper11 15分前

77 19 24 11 Tia

meixatech

meixatech 17分前

The Neuroscience Research Group, Danube Neuroscience Research Laboratory focuses on the kynurenine pathway. According to AI:

The kynurenine pathway (KP) is the primary metabolic route for the essential amino acid tryptophan. It connects the immune, metabolic, and nervous syst

Golden Cross

Golden Cross 18分前

$ILLR 🗞️ Eight Sports Capital Secures Major Enic Stake
🔗 https://www.goal.com/en-gh/lists/tottenham-daniel-levy-sells-35-percent-enic-stake-eight-sports-capital/bltada9f5dccfa90152

(Triller $ILLR owns Eight Sports Capital)

✨ A new e

Golden Cross

Golden Cross 19分前

$ILLR 🗞️ Eight Sports Capital Secures Major Enic Stake
🔗 https://www.goal.com/en-gh/lists/tottenham-daniel-levy-sells-35-percent-enic-stake-eight-sports-capital/bltada9f5dccfa90152

(Triller $ILLR owns Eight Sports Capital)

✨ A new e

1kgwxman

1kgwxman 20分前

Sticks and stones...sticks and stones.
Smart investors ignore the "noise" and go about their lives.
Nobody controls or influences their investment decisions except themselves.
Anonymous attacks on specific stocks like AMFN are irrelevant and impotent, as are those against invest

Eagle1

Eagle1 20分前

Good Morning and Yes indeed SDCRBS, Great to see you here!

jimr1717

jimr1717 21分前

Bingo! It’s all a ruse! There is nothing here other than shares to dump on marks.

FrostyIsland3

FrostyIsland3 22分前

I read the article and have sympathy for the guy, but the article does not go into his treatment for GBM. He strikes me as the sort of person who has the wealth to afford DCVax-L and I hope he is trying this treatment because it will probably lengthen his life.

jour_trader

jour_trader 22分前

Today’s US market value is about $8B. So if you take 20% (go generic) of that you’re at $1.6B. Take another 20% of that for Elite’s potential market share, but again only about half (take 50% of that) would show up as revenue in our P&L due to splits. Quick back of envelope math gives me about $200M

chemist72

chemist72 24分前

Please draw your own conclusions.
I'm not trying to push one narrative over another.

trunkmonk

trunkmonk 27分前

now why would i base my financial decisions on a nobody in a utube vid? waste of time.

Big Hook

Big Hook 28分前

How do you make money on app no one knows about.? Think about that. No advertising or marketing as of now.

georgejjl

georgejjl 31分前

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

https://www.cnbc.com/amp/2026/06/04/biotech-ma-dealmaking-pharma-106-billion.html

Good luck and GOD bless,

Sammy boy

Sammy boy 31分前

Another Christmas nearing ! Hard to believe, all talk no action ! The ECONOMY SUCKS don’t kid yourself !

sage007

sage007 33分前

Even if your assumptions about cancer numbers proved to be correct, one major issue is execution to perfection. I don’t really have confidence in this management to do so. Nevertheless, I do hope you are proven correct. I wouldn’t build any rosy expectations based on these assumptions of yours.

FACT II Acquisition

PowerShares S&P SmallCap...

Polaris Northstar Capital

0.01% Grn Bds 08/05/2036

Euronext Europe SBT 15 GR

Hsbc Msci Jp Ac

Packaging Corp Of America

HSBC Japan Screened Equi...

BEL Consumer Staples NR

Open Source Health Inc.

Mackenzie US Government ...

Casio Computer (PK)

Global X S&P 500 Collar ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。